News and Events

  • Explore Assays from DiaPharma to Enhance Your Anticoagulation Research

    Posted: May 14, 2025

    It’s Not Just Support. It’s Solutions. Anti-Xa Assay Kits Anti-Xa testing is integral to the development and evaluation of new anticoagulants, helping researchers understand the pharmacokinetics and pharmacodynamics of current and potential new drugs, leading to better strategies and innovations in anticoagulant therapy. DOAC Calibrators & Controls* High quality calibrators and controls for the reliable…

    Read More

  • Through the Lens of CK18:  Reflections on the AASLD ETC 2025: metALD and ALD

    Posted: March 31, 2025

    — Contributed by Olivia Stricker, PhD and Jessica Tuohy, PhD The 2025 AASLD Emerging Topics Conference in Las Vegas delivered an invigorating discussion on one of the most pressing challenges in hepatology today—metabolic dysfunction-associated alcohol-related liver disease (metALD) and the evolving landscape of ALD clinical trials. As research advances, our understanding of these diseases continues…

    Read More

  • Understanding the Chromogenic Factor X Assay: Its Value in Patient Care 

    Posted: March 21, 2025

    It’s Not Just Support. It’s Solutions. Understanding the Chromogenic Factor X Assay: Its Value in Patient Care  Key questions in managing warfarin patients include: The chromogenic Factor X assay measures % Factor X (FX) levels, which are useful for monitoring warfarin therapy in patients where the INR is unreliable. This makes it a valuable tool for healthcare providers…

    Read More

  • Assays to Enhance Anticoagulation Research

    Posted: March 21, 2025

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research DOAC-STOP™ Tablets* THE original DOAC eliminator Inhibitor Tubes* Simplify your laboratory’s research needs  Concerned about heparin interfering with your results? Introducing Antihepca™-HRRS*: MORE FROM DIAPHARMA: DOAC Calibrators & Controls* Apixaban ● Rivaroxaban ● Edoxaban ● Arixtra ● Dabigatran ● Orgaran Anti-Xa…

    Read More

  • Reliable Assays for Hemophilia Testing

    Posted: December 4, 2024

    It’s Not Just Support. It’s Solutions. Are you using the right reagents for Hemophilia testing? Hemophilia testing is complicated – DiaPharma scientists can help you choose the right assays for your testing needs. We offer a variety of kits and reagents to measure FVIII and FIX. Contact us to learn more. COAMATIC® FVIII (K822585) COATEST® SP FVIII (K824086) COATEST®…

    Read More

  • Introducing DOAC-Stop™ Liquid and Antihepca – new solutions for anticoagulation research

    Posted: November 18, 2024

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research DOAC-STOP™ Tablets* THE original DOAC eliminator Inhibitor Tubes* Simplify your laboratory’s research needs  Concerned about heparin interfering with your results? Introducing Antihepca™-HRRS*: MORE FROM DIAPHARMA: DOAC Calibrators & Controls* Anti-Xa Assay Kits Chromogenic Substrates and Reagents* *For research use only. Not…

    Read More

  • Meet Your Diabetes Drug Development Needs with TECO Intact Proinsulin

    Posted: November 14, 2024

    It’s Not Just Support. It’s Solutions. How can blood-based biomarkers enrich your Type 1 or Type 2 Diabetes Study population? TECO® Intact Proinsulin ELISA When it comes to measuring pancreatic Beta cell function, go with the pro! Save time and guess work by selectively measuring only intact proinsulin. Intact Proinsulin is produced by beta-cells (β-cells)…

    Read More

  • The Future of Thrombin Generation Testing

    Posted: November 11, 2024

    It’s Not Just Support. It’s Solutions. The Future of Thrombin Generation Testing Capture prothrombotic changes with global coagulation assays and expand your testing capabilities.  Ceveron® TGA Kits Automated, standardized thrombin generation assay Designed for use on the Ceveron® s100 (Item 9822210) coagulation analyzer Suitable for studies investigating effects of novel therapies Trigger reagent options with optimized Tissue Factor and Phospholipid…

    Read More

  • Connect with DiaPharma – see where we’ll be!

    Posted: September 12, 2024

    It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the cytokeratin 18 (CK18) biomarker assays, M30® Apoptosense and M65 ELISA®, for MASH, ALD/AH, DILI , or any of our other cutting edge products? Make…

    Read More

  • Connect with DiaPharma – see where we’ll be!

    Posted: September 11, 2024

    It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the Ceveron s100*, the FDA-cleared T-TAS 01, Technozym ADAMTS13 Activity ELISA for IVD use, M30® Apoptosense ELISA for liver damage, or any of our other…

    Read More

  • You’re Invited to an Online Seminar: T-TAS® 01: Ex vivo measurement of thrombus formation with a simple flow chamber system

    Posted: August 22, 2024

    It’s Not Just Support. It’s Solutions. T-TAS 01®: ex vivo measurement of thrombus formation with a simple flow chamber system We invite you to an online seminar: T-TAS® 01: ex vivo measurement of thrombus formation with a simple flow chamber system This online seminar provides the fundamental explanations for T-TAS (Total Thrombus-formation Analysis System) including…

    Read More